Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. Silo Pharma Soars On Positive Data For Its Arthritis Drug Candidate
  2. Bitcoin Whales Accumulated $3.5 Billion Worth of $BTC in 11 Weeks
  3. Markets Remain Cautious Ahead Of Monetary Policy Reviews
  4. Zymeworks Up 10% On Positive Study Results Of Zanidatamab In Biliary Tract Cancer Treatment
  5. US Presidential Candidate Pledges Dollar Backing With Bitcoin, No Bitcoin Capital Gains Tax